In about four years since its inception, Oceanpine has invested over 70 companies, over $3 billion has been invested, almost 30 of them have grown to unicorn companies and many of them have turned IPO already. As an institutional growth equity investment company formed by seasoned entrepreneurs and investors with 20 years of in-depth industry operational and business building experiences in both China and the US, Oceanpine is well positioned to the goal of building a well-respected top-tier investment firm. With a perspective of achieving successful growth over the long term together, Oceanpine partners visionary entrepreneurs to build world-class companies together over a period of years rather than on the short-term impact. Our profound industrial and business partners' network, resources and know-how not only enable us to discover truly proprietary companies with huge growth potential, but also provide tremendous value-added services to our entrepreneur partners and therefore foster their further growth. We invest innovative and disruptive growth companies in both TMT and healthcare sectors, i.e., DeepTech areas, which are the driving force of the future economy in the New Norm. We believe in long term value investing, and provide strategic resources and operational support to our companies. We invest across China and the world from our offices in Beijing, Shanghai, Hong Kong, and Silicon Valley. Our professional team consists of successful entrepreneurs, seasoned investors, sophisticated investment bankers and experienced industry executives and experts with proven track records in both China and the US. Meanwhile, we focus on attracting exceptionally talented people and rewarding excellence, initiative, independent thinking and integrity. We have a strong company culture built upon the core values of "Excellence, Integrity, and Entrepreneurship", which we believe are a fundamental strength of our business.